SAN DIEGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today reported financial results for the second quarter ended June 30, 2025. “We continued to execute on our new strategy of ...
Bionano is guiding for full-year 2026 revenue of $30 million to $33 million, representing 5% to 16% growth over 2025. Q1 2026 revenue guidance is $6.5 million to $6.7 million, described as "flat to 3% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results